drugset / Trial / NCT03990688
A Study to Assess the Effect of AK3280 on Renal Function in Healthy Subjects
RandomizedParallel-groupTriple-blindTreatment
Summary
AK3280 is being developed to further improve the long-term efficacy and tolerability of treatment options for patients with fibrotic disorders.This study will evaluate the effect of AK3280 treatment on renal function and safety, and the PK of AK3280 compared with placebo in healthy subjects.
Timeline
- Start
- 2019-10-03
- Primary completion
- 2020-09-09
- Completion
- 2020-09-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AK3280 | Unknown | 100 mg | Oral |
Indications
No indication recorded.